CTT Financial Statements From 2010 to 2024
| CTTH Stock | USD 0.06 0.01 8.95% |
Check CTT Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CTT Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . CTT financial statements analysis is a perfect complement when working with CTT Pharmaceutical Valuation or Volatility modules.
CTT |
CTT Pharmaceutical Holdings Company Shares Outstanding Analysis
CTT Pharmaceutical's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current CTT Pharmaceutical Shares Outstanding | 21.32 M |
Most of CTT Pharmaceutical's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CTT Pharmaceutical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, CTT Pharmaceutical Holdings has 21.32 M of shares currently outstending. This is 88.19% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 96.27% higher than that of the company.
CTT Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CTT Pharmaceutical's current stock value. Our valuation model uses many indicators to compare CTT Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CTT Pharmaceutical competition to find correlations between indicators driving CTT Pharmaceutical's intrinsic value. More Info.CTT Pharmaceutical Holdings is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value CTT Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CTT Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About CTT Pharmaceutical Financial Statements
Investors use fundamental indicators, such as CTT Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although CTT Pharmaceutical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. Ctt Pharmaceutical is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in CTT Pink Sheet
CTT Pharmaceutical financial ratios help investors to determine whether CTT Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CTT with respect to the benefits of owning CTT Pharmaceutical security.